ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

XLO Xilio Therapeutics Inc

1.07
0.05 (4.90%)
Jun 08 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -21.22M-24.55M-20.21M-23.17M-23.53M-20.12M-17.36M-18.13M
Pre Tax Income -21.35M-24.61M-19.79M-22.47M-22.65M-19.36M-16.75M-17.66M
Net Income -21.35M-24.61M-19.79M-22.47M-22.65M-19.36M-16.75M-17.66M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -21.35M-24.61M-19.98M-22.47M-22.65M-19.36M-16.75M-17.66M
EBITDA -20.78M-24.19M-19.65M-22.83M-23.03M-19.72M-16.81M-17.78M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -19.03M-54.56M-75.04M-89.15M-79.13M
Pre Tax Income -17.31M-55.22M-75.8M-88.22M-76.4M
Net Income -17.31M-55.22M-75.8M-88.22M-76.4M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 0-8.424-2.771-3.217-2.774
EBIT -17.31M-55.22M-75.8M-88.22M-76.4M
EBITDA -18.79M-53.5M-73.55M-87.45M-77.33M